Feed TRUHF
TR

Truly International Holdings Limited TRUHF OTC · Technology · Hong Kong SAR China

$0.09 +0.00% +$0.00

Summary

46 / 100 · Bulios Score

What speaks for it

  • The share price is below the Bulios Fair Price.
  • Out of every 100 HKD of revenue, 28 HKD is left as free cash.
  • It bought back its own shares for $183.2M in the last fiscal year, 8.5% of its market value.

What to watch

  • Revenue fell by 5.1% a year over the last 3 years.
  • Out of every 100 HKD of revenue, only 1.5 HKD is left as net profit.
  • Operating profit covers the interest on its debt only 1.8 times.
  • It earns only 2.7 HKD a year on every 100 HKD of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $0.094

By our assumptions the business is worth more than its shares cost today.

P/E today 9.1 14% lower
5-year average P/E 10.6
P/E today 9.1
Hardware, Equipment & Parts industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 9.1 HKD for 1 HKD of yearly profit. Over the last five years it was 10.6 HKD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (HKD)

Diluted EPS (HKD)

Revenue fell by 5.7% a year over 5 years. Over the last 3 years it fell by 5.1% a year. Earnings per share fell by 2.9% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 HKD of revenue goes

Net profit, industry median (Hardware, Equipment & Parts) 7.0 HKD

Out of every 100 HKD of revenue, 1.5 HKD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 2.0 years of free cash flow. Its debt is larger than its cash. The debt score is low because of the debt-to-equity ratio (0.9x).

Financial health in detail

Does it pay a dividend?

High, at risk
Yield
10.87%
Paid out of profit
99%
Raised in a row
2 years

You receive $0.01 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy